Connection

Matteo Bassetti to Drug Monitoring

Back to Details
This is a "connection" page, showing publications Matteo Bassetti has written about Drug Monitoring.
Matteo Bassetti
Connection Strength
0.798
Drug Monitoring
  1. Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? Int J Antimicrob Agents. 2017 Feb; 49(2):255-258.
    View in: PubMed
    Score: 0.364
  2. Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study. J Antimicrob Chemother. 2019 12 01; 74(12):3588-3595.
    View in: PubMed
    Score: 0.112
  3. The safety of treatment options for acute bacterial skin and skin structure infections. Expert Opin Drug Saf. 2019 08; 18(8):635-650.
    View in: PubMed
    Score: 0.108
  4. Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review. J Neurovirol. 2017 12; 23(6):908-912.
    View in: PubMed
    Score: 0.096
  5. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections. Intensive Care Med. 2017 Jul; 43(7):1021-1032.
    View in: PubMed
    Score: 0.093
  6. Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2017 10; 61(10).
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.